REG - Haleon PLC - Director Declaration

HALEONAnnouncement

21/01/2026 14:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260121:nRSU8295Pa&default-theme=true

RNS Number : 8295P  Haleon PLC  21 January 2026

 

Haleon plc: Director Declaration

 

21 January 2026: Haleon plc (LSE/NYSE: HLN) announces that Dawn Allen, Chief
Financial Officer, has been appointed Chair of the Audit & Risk Committee
of ITV plc with effect from 5 March 2026.

 

Dawn has served as a Non‑Executive Director of ITV plc and a member of its
Audit & Risk Committee since 2 October 2023.

 

This notification is made in accordance with the requirements of Listing Rule
6.4.9R(2).

 

 

Amanda Mellor

Company Secretary

 

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans six major categories - Oral Health, Vitamins, Minerals and Supplements
(VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin
Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on
trusted science, innovation and deep human understanding.

 

For more information, please visit www.haleon.com (http://www.haleon.com/)
.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNBBMITMTJTBFF



            Copyright 2019 Regulatory News Service, all rights reserved